SHARE
Anti-Infective Agents - Global Market Outlook (2017-2023)

Anti-Infective Agents - Global Market Outlook (2017-2023)

Published: December 2017 ID: SMRC16868
Published: December 2017 ID: SMRC16868

1 Executive Summary        
          
2 Preface  
       
 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology       
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions                          
          
3 Market Trend Analysis        
 3.1 Introduction        
 3.2 Drivers        
 3.3 Restraints        
 3.4 Opportunities       
 3.5 Threats        
 3.6 Product Analysis       
 3.7 Emerging Markets       
 3.8 Futuristic Market Scenario      
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes       
 4.4 Threat of new entrants       
 4.5 Competitive rivalry       
          
5 Anti-Infective Agents Market, By Product      
 5.1 Introduction        
 5.2 Antifungal agents       
  5.2.1 Azoles        
   5.2.1.1 Posaconazole     
   5.2.1.2 Clotrimazole     
   5.2.1.3 Fluconazole     
   5.2.1.4 Itraconazole     
   5.2.1.5 Ketoconazole     
   5.2.1.6 Voriconazole     
  5.2.2 Polyenes       
  5.2.3 Allylamines      
  5.2.4 Macrolides derivatives     
  5.2.5 Cresemba      
  5.2.6 Echinocandins       
 5.3 Antiviral agents        
  5.3.1 Non-structural protein 5A (NS5A) inhibitors   
  5.3.2 Non-nucleoside reverse transcriptase inhibitors (NNRTIs)  
  5.3.3 Protease Inhibitors      
  5.3.4 Transcriptase Inhibitors     
  5.3.5 Neuraminidase inhibitors     
  5.3.6 Integrase strand transfer inhibitor    
  5.3.7 Chemokine receptor antagonist    
  5.3.8 DNA Polymerase Inhibitors     
  5.3.9 Nucleoside Analogs      
   5.3.9.1 Purine Nucleosides     
   5.3.9.2 Pyrimidine Nucleosides    
 5.4 Antituberculosis agents      
  5.4.1 Nicotinic acid derivatives     
  5.4.2 Rifamycin derivatives     
  5.4.3 Streptomyces derivatives     
  5.4.4 Aminosalicylates      
  5.4.5 Diarylquinolines      
  5.4.6 Hydrazide derivatives     
 5.5 Antitreponemal agents       
 5.6 Vaccines        
  5.6.1 DNA & Recombinant vector Vaccines    
  5.6.2 Toxoid vaccines      
  5.6.3 Live/attenuated Vaccines     
  5.6.4 Inactivated Vaccines     
 5.7 Antibacterial agents        
  5.7.1 Clindamycin      
   5.7.1.1 B-Lactam Antibiotics    
   5.7.1.2 Oxazolidinones     
   5.7.1.3 Aminoglycosides     
   5.7.1.4 Quinolones     
  5.7.2 Sulfonamides      
  5.7.3 Tetracyclines      
  5.7.4 Vancomycin      
  5.7.5 Cephalosporins      
  5.7.6 Carbapenems      
  5.7.7 Fluoroquinolones      
  5.7.8 Penicillins       
   5.7.8.1 Penicillinase resistant penicillins   
   5.7.8.2 Natural penicillins     
   5.7.8.3 Beta-lactamase inhibitors    
   5.7.8.4 Antipseudomonal penicillins    
   5.7.8.5 Aminopenicillins     
  5.7.9 Macrolides       
   5.7.9.1 Erythromycin     
   5.7.9.2 Sulfisoxazole     
   5.7.9.3 Azithromycin     
   5.7.9.4 Clarithromycin XL     
          
6 Anti-Infective Agents Market, By Geography      
 6.1 Introduction        
 6.2 North America       
  6.2.1 US       
  6.2.2 Canada       
  6.2.3 Mexico       
 6.3 Europe        
  6.3.1 Germany       
  6.3.2 UK       
  6.3.3 Italy       
  6.3.4 France       
  6.3.5 Spain       
  6.3.6 Rest of Europe      
 6.4 Asia Pacific        
  6.4.1 Japan       
  6.4.2 China       
  6.4.3 India       
  6.4.4 Australia       
  6.4.5 New Zealand      
  6.4.6 South Korea      
  6.4.7 Rest of Asia Pacific      
 6.5 South America       
  6.5.1 Argentina      
  6.5.2 Brazil       
  6.5.3 Chile       
  6.5.4 Rest of South America     
 6.6 Middle East & Africa       
  6.6.1 Saudi Arabia      
  6.6.2 UAE       
  6.6.3 Qatar       
  6.6.4 South Africa      
  6.6.5 Rest of Middle East & Africa     
          
7 Key Player Activities        
 7.1 Acquisitions & Mergers       
 7.2 Agreements, Partnerships, Collaborations and Joint Ventures   
 7.3 Product Launch & Expansions       
 7.4 Other Activities       
          
8 Leading Companies        
 8.1 Pfizer Ltd        
 8.2 Ranbaxy Laboratories Ltd      
 8.3 Sun Pharmaceutical Industries Ltd.     
 8.4 AstraZeneca Plc       
 8.5 Boehringer Ingelheim       
 8.6 Bristol-Myers Squibb Co      
 8.7 Abbott Laboratories       
 8.8 Bayer Healthcare AG       
 8.9 Cipla Ltd        
 8.10 GlaxoSmithKline Pharmaceuticals Ltd     
 8.11 Merck & Co., Inc       
 8.12 Novartis AG        
 8.13 Glenmark Pharmaceuticals Ltd      
 8.14 Lupin Ltd        
 8.15 Panacea Biotech Ltd       
 8.16 Claris Life Sciences Ltd    


List of Tables         
Table 1 Global Anti-Infective Agents Market Outlook, By Region (2014-2023) ($MN)   
Table 2 Global Anti-Infective Agents Market Outlook, By Product (2014-2023) ($MN)   
Table 3 Global Anti-Infective Agents Market Outlook, By Antifungal agents (2014-2023) ($MN)  
Table 4 Global Anti-Infective Agents Market Outlook, By Azoles (2014-2023) ($MN)   
Table 5 Global Anti-Infective Agents Market Outlook, By Polyenes (2014-2023) ($MN)  
Table 6 Global Anti-Infective Agents Market Outlook, By Allylamines (2014-2023) ($MN)  
Table 7 Global Anti-Infective Agents Market Outlook, By Macrolides derivatives (2014-2023) ($MN) 
Table 8 Global Anti-Infective Agents Market Outlook, By Cresemba (2014-2023) ($MN)  
Table 9 Global Anti-Infective Agents Market Outlook, By Echinocandins (2014-2023) ($MN)  
Table 10 Global Anti-Infective Agents Market Outlook, By Antiviral agents (2014-2023) ($MN)  
Table 11 Global Anti-Infective Agents Market Outlook, By Non-structural protein 5A (NS5A) inhibitors (2014-2023) ($MN)
Table 12 Global Anti-Infective Agents Market Outlook, By Non-nucleoside reverse transcriptase inhibitors (NNRTIs) (2014-2023) ($MN)
Table 13 Global Anti-Infective Agents Market Outlook, By Protease Inhibitors (2014-2023) ($MN) 
Table 14 Global Anti-Infective Agents Market Outlook, By Transcriptase Inhibitors (2014-2023) ($MN) 
Table 15 Global Anti-Infective Agents Market Outlook, By Neuraminidase inhibitors (2014-2023) ($MN) 
Table 16 Global Anti-Infective Agents Market Outlook, By Integrase strand transfer inhibitor (2014-2023) ($MN)
Table 17 Global Anti-Infective Agents Market Outlook, By Chemokine receptor antagonist (2014-2023) ($MN)
Table 18 Global Anti-Infective Agents Market Outlook, By DNA Polymerase Inhibitors (2014-2023) ($MN) 
Table 19 Global Anti-Infective Agents Market Outlook, By Nucleoside Analogs (2014-2023) ($MN) 
Table 20 Global Anti-Infective Agents Market Outlook, By Antituberculosis agents (2014-2023) ($MN) 
Table 21 Global Anti-Infective Agents Market Outlook, By Nicotinic acid derivatives (2014-2023) ($MN) 
Table 22 Global Anti-Infective Agents Market Outlook, By Rifamycin derivatives (2014-2023) ($MN) 
Table 23 Global Anti-Infective Agents Market Outlook, By Streptomyces derivatives (2014-2023) ($MN) 
Table 24 Global Anti-Infective Agents Market Outlook, By Aminosalicylates (2014-2023) ($MN)  
Table 25 Global Anti-Infective Agents Market Outlook, By Diarylquinolines (2014-2023) ($MN)  
Table 26 Global Anti-Infective Agents Market Outlook, By Hydrazide derivatives (2014-2023) ($MN) 
Table 27 Global Anti-Infective Agents Market Outlook, By Antitreponemal agents (2014-2023) ($MN) 
Table 28 Global Anti-Infective Agents Market Outlook, By Vaccines (2014-2023) ($MN)  
Table 29 Global Anti-Infective Agents Market Outlook, By DNA & Recombinant vector Vaccines (2014-2023) ($MN)
Table 30 Global Anti-Infective Agents Market Outlook, By Toxoid vaccines (2014-2023) ($MN)  
Table 31 Global Anti-Infective Agents Market Outlook, By Live/attenuated Vaccines (2014-2023) ($MN) 
Table 32 Global Anti-Infective Agents Market Outlook, By Inactivated Vaccines (2014-2023) ($MN) 
Table 33 Global Anti-Infective Agents Market Outlook, By Antibacterial agents (2014-2023) ($MN) 
Table 34 Global Anti-Infective Agents Market Outlook, By Clindamycin (2014-2023) ($MN)  
Table 35 Global Anti-Infective Agents Market Outlook, By Sulfonamides (2014-2023) ($MN)  
Table 36 Global Anti-Infective Agents Market Outlook, By Tetracyclines (2014-2023) ($MN)  
Table 37 Global Anti-Infective Agents Market Outlook, By Vancomycin (2014-2023) ($MN)  
Table 38 Global Anti-Infective Agents Market Outlook, By Cephalosporins (2014-2023) ($MN)  
Table 39 Global Anti-Infective Agents Market Outlook, By Carbapenems (2014-2023) ($MN)  
Table 40 Global Anti-Infective Agents Market Outlook, By Fluoroquinolones (2014-2023) ($MN)  
Table 41 Global Anti-Infective Agents Market Outlook, By Penicillins (2014-2023) ($MN)  
Table 42 Global Anti-Infective Agents Market Outlook, By Penicillinase resistant penicillins (2014-2023) ($MN)
Table 43 Global Anti-Infective Agents Market Outlook, By Natural penicillins (2014-2023) ($MN)  
Table 44 Global Anti-Infective Agents Market Outlook, By Beta-lactamase inhibitors (2014-2023) ($MN) 
Table 45 Global Anti-Infective Agents Market Outlook, By Antipseudomonal penicillins (2014-2023) ($MN)
Table 46 Global Anti-Infective Agents Market Outlook, By Aminopenicillins (2014-2023) ($MN)  
Table 47 Global Anti-Infective Agents Market Outlook, By Macrolides (2014-2023) ($MN)  
Table 48 Global Anti-Infective Agents Market Outlook, By Erythromycin (2014-2023) ($MN)  
Table 49 Global Anti-Infective Agents Market Outlook, By Sulfisoxazole (2014-2023) ($MN)  
Table 50 Global Anti-Infective Agents Market Outlook, By Azithromycin (2014-2023) ($MN)  
Table 51 Global Anti-Infective Agents Market Outlook, By Clarithromycin XL (2014-2023) ($MN)  

Note: North America, Europe, Asia Pacific, South America, Middle East and Africa are represented in above manner.

Select License Type

Single User License (PDF)
2 - 5 User License (PDF)
Site License (PDF)
Corporate License (PDF)

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials